Z94.2
Conditions
Interventions
Group 1: Routine patient informed consent (talk with physician and standardized informed consent sheet [ID1 by Thieme Compliance])
Group 2: Routine patient informed consent (talk with physician and st
Sponsors
Medizinische Hochschule Hannover
Eligibility
Sex/Gender
All
Age
17 Years to 75 Years
Inclusion criteria
Inclusion criteria: Due to receive 1st bronchoscopy after primary lung transplant by pulmonary transplant team
Exclusion criteria
Exclusion criteria: - Not eligible for structured informed consent i.e. severely ill - Severe visual impairment
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Patient satisfaction with informed consent process (VAS 0-10) via questionnaire after informed consent | — |
Secondary
| Measure | Time frame |
|---|---|
| 1.) Examiner rating (bronchoscopeur and bronchoscopy assistant) of patient collaboration and comfort [3 items, VAS]; examiner(s) are blinded towards group allocation 2.) Patient questionnaire regarding anxiety and stress before and after informed consent discussion (Spielberger State Trait Anxiety Inventory (STAI), Trait anxiety (2 items), 5-level scale 3.) Patient satisfcation with informed consent process and bronchoscopy (VAS) (Adapted from Brand et al 2019 Annals of Internal Medicine), 9 items, VAS + 3 items in the graphic novel group (VAS) 4.) Patient satisfaction with bronchoscopy (7 items, VAS) | — |
Countries
Germany
Contacts
Public ContactSusanne Hoyer
Medizinische Hochschule Hannover Klinik für Pneumolologie
Outcome results
None listed